BIO-TECHNE Corp

For the period ended Dec 31, 2025. Filed Feb 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 4, 2026

TECH$72.83+0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)


· · December 31, · · ·
· · 2025 · · June 30,
· · (unaudited) · · 2025
ASSETS · · · ·
Current assets: · · · ·
Cash and cash equivalents	$172,879	$162,186
Accounts receivable, less allowances of $4,448 and $4,215, respectively	184,614	206,876
Inventories	205,447	189,446
Current assets held-for-sale	—	12,332
Other current assets	74,492	37,460
Total current assets	637,432	608,300

Property and equipment, net	234,383	245,719
Right-of-use assets	68,249	73,399
Goodwill	980,561	980,935
Intangible assets, net	334,990	365,599
Other assets	267,084	283,916
Total assets	$2,522,699	$2,557,868
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Trade accounts payable	$26,269	$25,311
Salaries, wages and related accruals	45,026	65,791
Accrued expenses	20,337	25,663
Contract liabilities	31,030	32,571
Income taxes payable	2,476	10,770
Operating lease liabilities - current	13,710	14,098
Other current liabilities	1,578	1,645
Total current liabilities	140,426	175,849

Deferred income taxes	11,021	6,169
Long-term debt obligations	260,000	346,000
Operating lease liabilities	77,185	83,960
Other long-term liabilities	23,078	27,082

Shareholders’ equity:
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	—	—
Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 155,881,291 and 154,972,196 respectively	1,559	1,550
Additional paid-in capital	964,955	911,089
Retained earnings	1,106,819	1,066,049
Accumulated other comprehensive loss	(62,344)	(59,880)
Total shareholders’ equity	2,010,989	1,918,808
Total liabilities and shareholders’ equity	$2,522,699	$2,557,868

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.